Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01995487 · ClinicalTrials.gov registry record · NA

Study of BioNIR Drug Eluting Stent System in Coronary Stenosis

A NA study, sponsored by Medinol.

Completed
Registry status
NA
Development phase
1,919
Enrollment target

NCT01995487: Completed NA study, sponsored by Medinol.

NCT01995487 is a NA study that has completed, run by Medinol. The registered enrollment target is 1,919 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01995487, a NA study, has completed, sponsored by Medinol.

COMPLETED
Registry status
NA
Development phase
1,919 participants
Enrollment target

Study Summary

The BioNIR study aims to show that the BioNIR ridaforolimus eluting stent is non-inferior to the Resolute zotarolimus-eluting stent for the primary clinical endpoint of target lesion failure (TLF) at 12 months; that it is non-inferior to the Resolute for the secondary endpoint of angiographic in-stent late loss at 13 months; and that it is more cost-effective.

Primary Outcome

The primary endpoint of TLF at 12 months was defined as the composite of cardiac death, target vessel-related MI, or ischemia-driven TLR.

Interventions

  • DEVICE BioNIR
  • DEVICE Resolute

Trial Details

FieldValue
Enrollment Target 1,919 participants
Start Date 2014-01
Est. Completion 2020-11-30
Phase NA
Medinol

4 total trials

What the finished NCT01995487 record still lists

NCT01995487 is an interventional study that assigns participants to a tested intervention. Its 1,919 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% higher).

The record links to 0 conditions, and to 2 interventions - of which BioNIR is the first listed.

NCT01995487 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01995487 about?

NCT01995487 is a clinical study titled "Study of BioNIR Drug Eluting Stent System in Coronary Stenosis". The BioNIR study aims to show that the BioNIR ridaforolimus eluting stent is non-inferior to the Resolute zotarolimus-eluting stent for the primary clinical endpoint of target lesion failure (TLF) at 12 months; that it is non-inferior to the Resolute for the secondary endpoint of angiographic in-ste...

What is the current status of trial NCT01995487?

This trial is currently completed. It is a NA study. The enrollment target is 1,919 participants. The study started on 2014-01. Estimated completion is 2020-11-30.

What interventions are being tested in trial NCT01995487?

The interventions under investigation include: BioNIR (DEVICE), Resolute (DEVICE).

Who is sponsoring clinical trial NCT01995487?

This trial is sponsored by Medinol, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01995487's enrollment target sits among peer trials

1,919 55th of 2000 higher than 1,946 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06058455 · 1,920 participants · NA

    An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)

  • NCT05174169 · 1,912 participants · Phase 2

    Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

  • NCT06799117 · 1,912 participants · NA

    Adaptive Decision Support for Addiction Treatment Master

  • NCT05233150 · 1,932 participants · NA

    Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01995487, the US trial registry maintained by the National Library of Medicine. NCT01995487 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.